Exclusive

Olam Group Terminates $175 Mln Sale Agreement For Remaining ARISE P&L Stake

India, Nov. 16 -- Olam Group Limited (OLG) announced on Monday that its agreement to sell its remaining 32.4% stake in ARISE P&L Limited to Equitane DMCC for $175 million has been terminated after cer... Read More


Couche-Tard Receives Final Regulatory Approval For Zabka Offer

India, Nov. 16 -- Convenience store operator Alimentation Couche-Tard Inc. (ATD.TO) announced on Monday that it has received the final regulatory approval required for its previously announced offer t... Read More


Zealand Pharma Receives Approval In EU For Zeydovio In Short Bowel Syndrome

India, Nov. 16 -- Zealand Pharma A/S (ZEAL.CO), a biotechnology company, received a marketing authorization from the European Commission (EC) for Zeydovio in the treatment of short bowel syndrome. Th... Read More


Taylor Swift To Receive The Hollywood Reporter's Sherry Lansing Leadership Award

India, Nov. 16 -- The Hollywood Reporter has announced it will honor Taylor Swift with the prestigious Sherry Lansing Leadership Award this year during its annual Women in Entertainment breakfast gala... Read More


U.S. Stocks Sharply Lower Amid Continued Tech Sector Weakness

India, Nov. 16 -- Stocks have moved sharply lower during trading on Monday, extending the downward move seen over the two previous sessions. The major averages have all moved to the downside, with the... Read More


Moleculin Reports Q3 Results; Completes MIRACLE Trial Treatment With Data Expected In Q1 2027

India, Nov. 16 -- Moleculin Biotech, Inc. (MBRX) reported Monday third-quarter 2026 financial results and announced completion of treatment for all 90 patients in Part A of its pivotal Phase 2/3 MIRAC... Read More


MiniMed Gains FDA Approval For Tubeless Insulin Pump

India, Nov. 16 -- MiniMed (MMED) announced on Monday that the U.S. Food and Drug Administration has cleared MiniMed Fit, the company's first tubeless insulin pump, expanding its automated insulin deli... Read More


Prelude Q3 Loss Narrows On Lower R&D Costs; Breast Cancer Data Due In H2 2027

India, Nov. 16 -- Prelude Therapeutics Incorporated (PRLD) reported Monday a narrower third-quarter loss as research and development expenses declined. Company Profile Prelude is a clinical-stage pr... Read More


Weak Sentiment In Crypto Markets

India, Nov. 16 -- A weak trend prevails in global cryptocurrency markets amidst a strengthening in the U.S. Dollar, a mixed trend in bond markets, a decline in the prices of the yellow metal and crude... Read More


NextSource Materials Inc. Q1 Loss Declines

India, Nov. 16 -- NextSource Materials Inc. (NEXT.TO) released Loss for first quarter of -$6.307 million The company's earnings came in at -$6.307 million, or -$0.03 per share. This compares with -$7... Read More